Clinical Trial Update: BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's Jaundice [NA]

View source ↗

Summary

A clinical trial update announces BUBOLight, a phototherapy device, being studied for neonatal jaundice and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Jaundice

Drugs mentioned

• BUBOLight phototherapy device

Snippet

Sponsor: University Hospital, Lille | Conditions: Neonatal Jaundice | NA | Status: RECRUITING